This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Tortora, G. Articles by Ciardiello, F. Search for Related Content PubMed PubMed Citation Articles by Tortora, G. Articles by Ciardiello, F.

Synergistic Inhibition of Growth and Induction of Apoptosis by 8-Chloro-cAMP and Paclitaxel or Cisplatin in Human Cancer Cells¹

Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Facoltà di Medicina e Chirurgia, Università degli Studi di Napoli Federico II, 80131 Naples, Italy

8-Chloro-cAMP (8-Cl-cAMP) is a novel agent that is able to inhibit the growth of a wide variety of cancer cell types in vitro and in vivo and, at doses devoid of toxicity, to achieve plasma concentrations in cancer patients in a range effective for cancer cell growth inhibition. In this study, we have demonstrated that 8-Cl-cAMP, at a dose causing mild or no growth inhibition, synergistically increased the growth-inhibitory effect of paclitaxel or cisplatin in a wide series of cell lines including human breast, lung, ovary, colon, and head carcinomas and melanoma. A similar effect was also observed with another taxane, docetaxel, and with the platinum-derivative carboplatin. 8-Cl-cAMP also markedly enhanced apoptotic cell death induced by each cytotoxic drug. A cooperative antitumor effect was also observed in vivo, because treatment with paclitaxel followed by 8-Cl-cAMP markedly inhibited the growth of GEO human colon cancer xenografts as compared to paclitaxel alone without signs of toxicity. These data demonstrate that 8-Cl-cAMP synergistically increases the antiproliferative activity of taxanes and platinum-derived compounds and provide a rationale to use 8-Cl-cAMP in combination with taxanes and platinum-derived compounds.

¹ Supported by grants from the Associazione Italiana per la Ricerca sul Cancro and from the Progetto Finalizzato Applicazioni Cliniche Ricerca Oncologica (Consiglio Nazionale delle Ricerche).

² To whom requests for reprints should be addressed, at Cattedra di Oncologia Medica, Dipartimento di Endocrinologia e Oncologia Molecolare e Clinica, Università degli Studi di Napoli Federico II, Via S. Pansini 5, 80131 Naples, Italy. Phone: 39-81-7462061; Fax: 39-81-7462066.

Received 7/14/97. Accepted 8/27/97.

This article has been cited by other articles:

				L. B. KORICANAC, D. V. TODOROVIC, N. M. POPOVIC, M. A. DEMAJO, S. D. RUZDIJIC, and A. M. RISTI-FIRA Inhibition of B16 Mouse Melanoma Cell Growth and Induction of Apoptotic Cell Death with 8-Chloroadenosine-3',5'-monophosphate and Tiazofurin Ann. N.Y. Acad. Sci., December 1, 2004; 1030(1): 384 - 392. [Abstract] [Full Text] [PDF]

				C. M. Stellrecht, C. O. Rodriguez Jr., M. Ayres, and V. Gandhi RNA-Directed Actions of 8-Chloro-Adenosine in Multiple Myeloma Cells Cancer Res., November 15, 2003; 63(22): 7968 - 7974. [Abstract] [Full Text] [PDF]

				G. TORTORA and F. CIARDIELLO Protein Kinase A as Target for Novel Integrated Strategies of Cancer Therapy Ann. N.Y. Acad. Sci., June 1, 2002; 968(1): 139 - 147. [Abstract] [Full Text] [PDF]

				F. Ciardiello, R. Bianco, V. Damiano, S. De Lorenzo, S. Pepe, S. De Placido, Z. Fan, J. Mendelsohn, A. R. Bianco, and G. Tortora Antitumor Activity of Sequential Treatment with Topotecan and Anti-Epidermal Growth Factor Receptor Monoclonal Antibody C225 Clin. Cancer Res., April 1, 1999; 5(4): 909 - 916. [Abstract] [Full Text] [PDF]

				H. M. McDaid and P. G. Johnston Synergistic Interaction between Paclitaxel and 8-Chloro-adenosine 3',5'-Monophosphate in Human Ovarian Carcinoma Cell Lines Clin. Cancer Res., January 1, 1999; 5(1): 215 - 220. [Abstract] [Full Text] [PDF]

				R. K. Srivastava, A. R. Srivastava, S. J. Korsmeyer, M. Nesterova, Y. S. Cho-Chung, and D. L. Longo Involvement of Microtubules in the Regulation of Bcl2 Phosphorylation and Apoptosis through Cyclic AMP-Dependent Protein Kinase Mol. Cell. Biol., June 1, 1998; 18(6): 3509 - 3517. [Abstract] [Full Text]